ArticleAdvanced therapeutics2022

Dimethylaminomicheliolide Sensitizes Cancer Cells to Radiotherapy for Synergistic Combination with Immune Checkpoint Blockade.

Yingying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.